KRAS and colorectal cancer: The association between KRAS G12D mutation and low CRS signature in current study may have stemmed from the limited response to chemotherapy in KRAS G12D mutation harboring colorectal cancer,29 although the relationship between specific KRAS mutation status and response to radiotherapy is largely unknown.